MSTR price
$137.95
+$14.76 · +12.0%
Strategy Stock Rises 12%, Surges Ahead of Bitcoin Four Times as BTC Hits $80,000
Strategy stock surged 12% on Thursday after bitcoin topped $80,000. The equity posted a gain nearly four times higher than the cryptocurrency's daily return.
NASDAQ: MSTR · BITCOIN TREASURY
Equity leverage returns as bitcoin clears $80,000
Market: Aug. 27, 2026, 11:53 ET
Holdings and liquidity: Aug. 23, 2026
Holdings and liquidity: Aug. 23, 2026
Bitcoin
$80,367
+$2,262 · +2.9%
Bitcoin held
840,447
4.0% of maximum supply
Dollar liquidity
$6.69B
Reserve + flexible cash
One-day return: common stock versus bitcoin
The common stock added roughly $5.2 billion of quoted value. The bitcoin reserve gained about $1.9 billion at the same snapshot.
Reserve sensitivity
Gross bitcoin value
$67.5B
Unrealized gross gain
≈$4.2B
Value change per $1,000 BTC move
≈$840M
Before debt, preferred equity, tax and other claims.
Capital structure and operating signals
| Measure | Reading | Why it matters |
|---|---|---|
| BTC acquisition cost | $63.36B / $75,385 each | Current token price sits 6.6% higher |
| USD Reserve | $5.10B | Supports dividends and interest |
| USD Cash | $1.59B | Flexible treasury deployment |
| Q2 long-term debt | $6.7B | Down 18% in the quarter |
| Q2 preferred equity | $14.4B | Senior claim to common stock |
| Q2 software revenue | $122.4M | Up 6.9% year over year |
Latest capital allocation
| Action, Aug. 17–23 | Amount | Investor interpretation |
|---|---|---|
| MSTR shares sold | 18.26M | Common-stock dilution |
| Net proceeds | $2.0065B | About $109.88 per share |
| STRC repurchase | $136.4M | Reduces preferred claim |
| USD Reserve increase | $300M | Extends obligation coverage |
| Bitcoin traded | None | 840,447 BTC unchanged |
Analyst markers
Canaccord
$175
Buy · raised Aug. 25
Bernstein
$350
Outperform · cut Aug. 26
Risk frame
MSTR’s daily gain materially exceeded bitcoin’s. That leverage can reverse. Common issuance, preferred dividends, debt service, tax changes, regulation and contraction of the equity multiple can outweigh a stable token price.
Primary data: Strategy Aug. 24 Form 8-K and Q2 2026 results. Market data timestamped above.
ServiceNow Shares Surge 9%—$11.7 Billion Gain Linked to Salesforce AI Results Shifting Software Valuations
SANTA CLARA, California, August 27, 2026, 10:37 EDT — ServiceNow's stock soared 9%, translating to an added $11.7 billion in market value as Salesforce's recent AI-driven financial results sparked a broad revaluation of software sector stocks.
NYSE: NOW · Stock move
ServiceNow re-rating dashboard
Salesforce's AI results pulled enterprise software higher.
Market snapshot
Aug. 27, 2026 · 10:37 EDT
Aug. 27, 2026 · 10:37 EDT
NOW price
$137.16
+9.03% · +$11.36
Value created
≈$11.7B
Based on 1.03B shares
Volume
10.52M
64.7% of 20-day average by 10:37
Consensus upside
3.7%
$142.23 average target
The gap compressed
What powered the move
Salesforce stock+20.75%
Agentforce + Data 360 ARR$3.9B · +210%
Agentforce ARR>$1.5B · +240%
FY27 revenue outlook$46.1B-$46.4B
Salesforce market data at 10:28 EDT; operating metrics released Aug. 26.
ServiceNow operating engine
Q2 subscription revenue$3.877B · +24.5%
Q2 cRPO$13.20B · +21%
Q2 RPO$29.0B · +21%
FY26 subscription guide$15.760B-$15.780B
FY26 FCF margin guide35%
Valuation and expectations
Market capitalization$141.80B
Forward P/E27.76×
Forward price/sales7.36×
EV/free cash flow28.78×
Analyst ratingStrong Buy · 49 analysts
Software read-through
| Company | Price | Move |
|---|---|---|
| ServiceNow (NOW) | $137.16 | +9.03% |
| Salesforce (CRM) | $248.29 | +20.75% |
| Workday (WDAY) | $197.39 | +3.48% |
| Oracle (ORCL) | $150.84 | +1.32% |
NOW at 10:37 EDT; peer prices at about 10:28 EDT on Aug. 27, 2026.
Near-term checks
2:40 p.m. EDT today
ServiceNow CFO Gina Mastantuono speaks at Deutsche Bank's technology conference.
Next quarter
Watch whether cRPO holds near 20% constant-currency growth and AI ACV converts into subscriptions.
Risk
The rally is a peer read-through. Average target upside is now only 3.7%.
Trend context, correctly dated
The U.S. search phrase “now stock” also points to ServiceNow's expanded Tech Mahindra partnership. It was announced Aug. 20, not today. Tech Mahindra says its ServiceNow deployment handles more than 100,000 monthly cases across 90 countries, supports 150,000 employees and has optimized about 25% of first-level support work.
Revenue and bookings proofValuation re-ratingExecution checkpoint
Moderna Shares Drop 5.0%, Wiping Out $3.0 Billion as $2 Billion Convertible Notes Offering Challenges Cancer-Vaccine Surge
CAMBRIDGE, Massachusetts, August 27, 2026, 10:15 Moderna stock slid 5.0% on Thursday, shaving $3.0 billion off its market value, after the company announced a $2 billion convertible notes sale, testing investor appetite following a recent rally in its cancer-vaccine business.
Moderna, Inc. · NASDAQ: MRNA
Convertible financing resets the rally math
Intraday snapshot: August 27, 2026, 10:15:13 EDT
Share price
$142.20
−$7.46 · −4.98%
Market cap
$56.54B
Implied loss: ~$2.97B
Base notes
$2.0B
Up to $2.3B with option
Trading activity
7.34M
Shares by 10:15 EDT
Session path
The stock recovered from its session low but remained 5.0% below Wednesday’s close.
Investor bridge
Equity value lost / base notes
1.48×
Base notes / June liquidity
28.9%
The market erased about $2.97 billion while Moderna proposed $2.0 billion of base financing.
Financing terms
| Term | Current disclosure |
|---|---|
| Security | Senior unsecured convertible notes |
| Maturity | 2032 |
| Regular interest | None |
| Purchaser option | $300M for 13 days |
| Settlement | Cash, shares or both |
| Capped-call threshold | At least 150% premium at pricing |
Liquidity and burn
| Metric | Amount | Read-through |
|---|---|---|
| Cash + investments | $6.9B | June 30 |
| Q2 operating cash outflow | $526M | Base notes = 3.8× |
| Q2 net loss | $782M | Base notes = 2.6× |
| July settlement payment | $950M | Post-quarter cash use |
| 2026 year-end cash guide | $4.7B–$5.2B | Before new deal update |
Catalyst timeline
July 31 · Q2 resultsRevenue $145M; net loss $782M; year-end cash guidance improved to $4.7B–$5.2B.
August 19 · Melanoma Phase 3Positive recurrence-free and distant-metastasis-free survival results drove a sharp pipeline revaluation.
August 27 · Convertible proposal$2.0B base deal, plus $300M option; pricing and conversion terms remain pending.
Analyst expectations
Consensus
Hold
23 analysts · average target $104.53
−26.5% versus $142.20
Target dispersion is wide after the oncology-data rally. The financing terms now add a separate dilution and balance-sheet variable.
What the stock is pricing
The financing converts part of the recent oncology revaluation into liquidity. No regular coupon limits cash interest, but conversion can expand the share count. The capped call only protects up to its final cap.
Next checks
Pricing: conversion rate, premium and net proceeds.
Hedging: capped-call cost and counterparties’ trading.
Use of funds: oncology investment versus debt repayment.
Risk trigger: weaker clinical or regulatory progress after leverage rises.
Sources: Moderna August 27 financing announcement; Moderna July 31 quarterly results; Google Finance; MarketScreener. Calculations use the $142.20 share price and $56.54 billion market capitalization observed at 10:15:13 EDT on August 27, 2026. Values are rounded.
Micron Shares (MU) Retreat Nearly Entirely After Nvidia Surge, $1,300 Target Remains in Play
BOISE, Idaho, August 27, 2026, 09:39 EDT — Micron Technology's stock has erased 82% of its Nvidia-driven opening gap, with attention staying on its projected $1,300 price target.
Google Trend: MU · NASDAQ:MU
Micron’s Nvidia gap faded fast
The AI-memory read-through remains strong. Price action says investors still want Micron-specific proof on HBM volume, pricing and margins.
Market open · 09:39 EDT
Micron price
$943.46
+$5.06 · +0.54%
Opening gap
+3.05%
82% erased by 09:39
$1,300 target
+37.8%
8.4× FY2027 EPS estimate
Analyst consensus
$1,515
Strong Buy · 47 analysts
Ten-session price path
August 27 value is intraday at 09:39 EDT; earlier values are official closes. The stock opened at $967.01 before fading.
Fundamentals and valuation
| Metric | Current / latest | Comparison | Investor reading |
|---|---|---|---|
| Fiscal Q3 revenue | $41.46B | $23.86B prior quarter | +73.8% sequential |
| Operating cash flow | $25.39B | $11.90B prior quarter | Cash conversion strengthened |
| Adjusted free cash flow | $18.3B | $7.1B capex | Funds expansion internally |
| Adjusted gross margin | 84.9% | 74.9% prior quarter | Exceptional, hard to sustain |
| Forward P/E | 6.5× | 21.2× trailing | Large earnings-cycle assumption |
| Net cash | $23.75B | $21.03 per share | Balance-sheet cushion |
AI-memory transmission chain
Nvidia Q2 revenue
$96.2B
+106% year over year
Data-center revenue
$89.0B
+117% year over year
Nvidia Q3 outlook
$108B
±2%; excludes China compute
Micron HBM4
>2.8 TB/s
36GB 12-high; Rubin design
HBM is stacked memory placed beside AI accelerators. Higher accelerator shipments increase the addressable memory content, but Micron’s realized revenue still depends on qualification, allocation, pricing and yield.
Targets and next check
| Reference | Target / value | Upside from $943.46 | Implied FY2027 P/E |
|---|---|---|---|
| Current price | $943.46 | — | 6.1× |
| BMO / Mizuho | $1,300 | 37.8% | 8.4× |
| Analyst average | $1,515 | 60.6% | 9.8× |
| Analyst low | $361 | −61.7% | 2.3× |
| Analyst high | $2,200 | +133.2% | 14.2× |
Next dated catalyst: Micron reports fiscal fourth-quarter results on September 30 at 2:30 p.m. Mountain time. Watch HBM shipments, memory pricing, gross margin and fiscal 2027 capex.
Main risk: A slower AI-server buildout, weaker HBM pricing or faster rival capacity additions could compress the earnings estimate that makes Micron appear inexpensive.
VolitionRx Shares Surge 97.5% Before Market Open as Sepsis Test Validation Sparks Tenfold Volume
VolitionRx Limited stock surged almost 100% ahead of Thursday’s U.S. market open, following news of clinical validation for its Nu.Q NETs blood biomarker in sepsis. Shares reached $0.67 at 07:30 EDT, marking a gain of 97.49%, with premarket volume at 143.86 million shares.
VolitionRx Limited · NYSE American: VNRX
Sepsis validation reprices a cash-burning microcap
Market: Aug. 27, 2026, 07:30 EDT
Financials: Q2 ended June 30, reported Aug. 13
Financials: Q2 ended June 30, reported Aug. 13
Premarket price
$0.67
+97.49% · +$0.33
Premarket volume
143.86M
10.5× implied shares outstanding
Implied value added
$4.50M
86.6% of Q2 operating cash use
Implied equity value
$9.15M
At $0.67 and 13.65M implied shares
Trading and operating snapshot
| Measure | Period | Value |
|---|---|---|
| Close before catalyst | Aug. 26 | $0.34 |
| Premarket range | Aug. 27, 07:30 EDT | $0.66–$0.68 |
| Q2 revenue | Quarter ended June 30 | ~$0.4M |
| H1 revenue | Six months ended June 30 | $1.4M · +112% |
| Q2 operating loss | Quarter ended June 30 | $4.2M · −34% |
| Q2 operating cash use | Quarter ended June 30 | $5.2M · −18% |
| Cash | June 30 | $2.79M |
Scale comparison
The market added almost one quarter's cash consumption. That is meaningful for a microcap, but small beside the funding needed to commercialize diagnostics.
Catalyst-to-revenue ladder
Peer-reviewed clinical validation
→
Licensing agreement
→
Regulatory and reimbursement path
→
Routine clinical adoption
→
Recurring assay revenue
Status at Aug. 27: validation completed; commercial discussions disclosed, but no contract value or revenue timetable announced. The $2.8B annual sepsis opportunity is a company estimate, not guidance.
Commercial riskIndependent validation may not convert into licensing economics, reimbursement or hospital uptake.
Financing riskJune 30 cash was below one quarter's operating cash use. Shares, warrants and an ATM facility funded Q2.
Trading riskPremarket turnover exceeded ten times implied shares. Thin liquidity can amplify both gains and reversals.
Sources: Public market data; VolitionRx clinical release; Q2 results; Yahoo Finance statistics. Calculations use rounded public figures.
NVIDIA Stock Jumps 7.4% Premarket, Adding $374 Billion After $96.2 Billion Quarter
NVIDIA Corporation rose 7.37% to $225.12 in premarket trading at 05:43 EDT. The move followed quarterly revenue that more than doubled and a forecast above Wall Street expectations.
NASDAQ: NVDA · Earnings
$96.2bn quarter reprices a $5tn stock
The revenue beat mattered. The $108bn guide and 70% FY2028 growth signal mattered more.
Market snapshot
Aug. 27, 2026 · 05:43 EDT
Aug. 27, 2026 · 05:43 EDT
Premarket
$225.12
+7.37% vs. Aug. 26 close
Implied value added
$374bn
$15.46 × 24.19bn basic shares
Q2 revenue
$96.22bn
+18% Q/Q · +106% Y/Y
Q3 midpoint
$108.0bn
+12.2% sequential · ±2%
Revenue scale
USD billions. Q3 is management's Aug. 26 midpoint; range is $105.84bn–$110.16bn.
What drove attention
Data Center share uses Q2 revenue. Growth figures are company-reported.
Fundamentals and cash signals
| Metric | Current | Comparison |
|---|---|---|
| GAAP gross margin | 75.0% | 74.0% Q3 midpoint |
| GAAP operating income | $63.73bn | +124% Y/Y |
| Operating cash flow | $24.08bn | Q2 FY2027 |
| Accounts receivable | $63.06bn | +64% since Jan. 25 |
| Inventory | $31.58bn | +48% since Jan. 25 |
| Capital returned | $26.0bn | Q2 buybacks + dividends |
Valuation and expectations
| Forward P/E | 17.9× |
| AMD forward P/E | 37.2× |
| Intel forward P/E | 46.2× |
| Analyst consensus | Buy · 61 analysts |
| Average target | $305.79 |
| Raymond James | Strong Buy · $352 |
Consensus and targets observed Aug. 27; latest rating dated Aug. 25. Forward multiples reported by Reuters Aug. 27.
Transmission and risks
Margin: Q3 gross-margin midpoint falls 100 basis points despite faster revenue.
China: The $108bn guide assumes no Data Center compute revenue from China.
Working capital: Receivables and inventory expanded materially since January; slower collections or demand would expose both.
Market test: The premarket gain equals 3.9× one quarter of revenue. Thursday's regular session will test whether that repricing holds.
D-Wave Quantum Shares Slide 9.5%, Wiping Out $679 Million as CFO Steps Down
D-Wave Quantum Inc. shares dropped 9.51% on Wednesday following news of the chief financial officer's retirement. The stock ended the session at $17.51, before climbing 2.11% to $17.88 in after-hours trade at 19:59 EDT.
D-Wave Quantum: CFO-transition selloff
NASDAQ:QBTS • company stock move
Market data: Aug. 26, 2026, 19:59 EDT
Prepared: Aug. 27, 2026, 10:38 CEST
Prepared: Aug. 27, 2026, 10:38 CEST
Regular close
$17.51
−9.51% • −$1.84
After hours
$17.88
+2.11% • +$0.37
Value erased
$679M
Estimated on 369.26M shares
Net unrecovered
$543M
After $137M late rebound
Price path
The after-hours recovery replaced about 20% of the regular-session equity-value loss.
Trading pressure
Volume
26.53M
109% of 65-day average (24.33M)
Distance from 52-week high
−62.5%
Range: $12.75–$46.75
Governance timeline
Aug. 19Markovich gives notice
Aug. 25Retirement announced
Aug. 26Shares fall 9.51%
Sep. 2Golkov becomes acting CFO
The SEC filing says the resignation was not caused by a disagreement over operations, accounting, disclosures or controls.
Financial execution test
| Q2 revenue | $3.1M |
| Q2 GAAP operating expenses | $55.0M |
| Q2 adjusted EBITDA loss | $37.1M |
| First-half bookings | $35.5M |
| Remaining obligations | $40.7M |
| Cash + securities | $546.2M |
The $543M unrecovered value equals 15.3× first-half bookings and roughly 175× quarterly revenue.
Quantum peer snapshot — Aug. 26 close
| Company | Close | Move | Market cap |
|---|---|---|---|
| D-Wave | $17.51 | −9.51% | $6.52B |
| IonQ | $40.03 | −4.83% | $14.72B |
| Rigetti | $15.94 | −5.87% | $5.31B |
| Quantum Computing | $8.35 | −1.24% | $1.88B |
Analyst expectations
Buy
Mean recommendation • 17 analysts
Low $22Average $35.24High $43The average target is 101% above the $17.51 close. Targets are estimates, not guarantees.
What can break the case
Large system contracts make revenue recognition uneven. First-half bookings included one $20 million sale. A slower conversion of the $40.7 million obligation balance, continued operating-cost growth, or another finance-management change would increase valuation pressure. Continuity on September 2 is the next confirmed governance checkpoint.
Wendy’s Shares Drop 13.3% After Hours Following Trian Statement Ruling Out Bid
Shares in The Wendy’s Company dropped after Reuters disclosed that Trian Fund Management, led by Nelson Peltz, does not presently intend to make an offer for the fast-food chain. The stock declined $1.20 in after-hours trading to reach $7.84 at 19:59 EDT.
NASDAQ: WEN · takeover premium reset
Wendy’s investor dashboard
Market data: Aug. 26, 2026, 19:59 EDT
Dashboard prepared: Aug. 27, 2026, 05:08 CEST
Dashboard prepared: Aug. 27, 2026, 05:08 CEST
After-hours price
$7.84
−13.27% · −$1.20
Quoted value erased
≈$229M
$1.20 × 190.67M shares
Analyst target gap
+$0.05
0.6% above $7.79 average
After-hours volume
2.52M
31.6% of regular-session volume
Bid-premium path
Regular closesAfter-hours repricing
Market-value bridge
Aug. 11 close$7.55≈$1.44B
Aug. 26 close$9.04≈$1.72B
Aug. 26 AH$7.84≈$1.49B
- The late drop exceeded the roughly $212M added on Aug. 12.
- Only about $55M of price uplift remained versus Aug. 11.
- Trian owns about 16%; no formal bid price exists.
Operating dashboard · Q2 2026
| Metric | Result | Year over year |
|---|---|---|
| Revenue | $570.6M | +1.7% |
| U.S. same-restaurant sales | — | −7.0% |
| U.S. systemwide sales | $2.88B | −8.2% |
| U.S. restaurant margin | 13.8% | −240 bps |
| Operating profit | $79.3M | −24.0% |
| Net income | $32.6M | −40.8% |
| H1 free cash flow | $120.3M | +9.9% |
Estimate pressure
FactSet current estimates on Aug. 26. One month earlier: $0.14, $0.57 and $0.64, respectively.
Peer valuation
| Company | P/E | Consensus |
|---|---|---|
| Wendy’s | 13.7x | Hold |
| Restaurant Brands | 21.4x | Buy |
| Yum! Brands | 19.5x | Buy |
What moves the stock next
Deal path
A changed Trian stance, another bidder or a formal filing would rebuild optionality.
Traffic
U.S. same-store sales must improve from the Q2 decline.
Margins
Commodity and wage inflation are pressuring restaurant economics.
Next report
Q3 earnings are expected Nov. 11, 2026.
Sources: Reuters, The Wendy’s Company Q2 2026 release, FactSet via The Wall Street Journal, StockAnalysis and Investing.com. Market-value calculations use 190.67 million shares outstanding. After-hours prices can reflect limited liquidity and may not predict the next regular-session open.
SpaceX Shares Gain 1.2% After $100 Billion Louisiana Starbase Valued at Par With Company Cash
Shares in SpaceX advanced on Wednesday following the announcement of a $100 billion Louisiana spaceport. Space Exploration Technologies Corp. finished the session at $139.63, up 1.22%.
NASDAQ: SPCX · product/commercial catalyst
$100B Starbase meets a $100B cash pool
The Louisiana plan can expand Starship capacity across launch, Starlink and orbital AI. The valuation question is how SpaceX phases a project equal to all second-quarter liquidity.
Regular close: Aug. 26, 2026, 16:00 EDT
After-hours quote: Aug. 26, 16:36 EDT
Dashboard: Aug. 26, 19:58 EDT
After-hours quote: Aug. 26, 16:36 EDT
Dashboard: Aug. 26, 19:58 EDT
Regular close · Aug. 26
$139.63
+$1.68 · +1.22%
After hours · 16:36 EDT
$139.05
−0.42% from close
Regular volume · Aug. 26
56.1M
Yahoo Most Active
Closing market value
≈$1.84T
Project equals 5.4%
Capital scale
Project spending is a total plan, not a disclosed one-year budget. Liquidity and backlog are as of June 30, 2026.
Louisiana buildout
Investment$100B
Site125,000 acres
Launch complexes5
Planned pads10
Construction target2027
First-launch target2029
Q2 2026 financial base
Total revenue$7.81B
Year-over-year growth+92%
Adjusted EBITDA$3.54B
Net result−$541M
Total capex$18.37B
Cash + securities$100B
Space segment
Q2 revenue$962M
Revenue growth+29%
Operating result−$542M
Adjusted EBITDA−$205M
Q2 capex$1.17B
H1 launches78
Commercial channels
Connectivity revenue$4.29B
Starlink subscribers12.0M
AI revenue$2.56B
Government awards>$6B
Total backlog$47.5B
Next resultsNov. 5, 2026
Analyst expectations · Aug. 26 close
ConsensusModerate Buy
Tracked ratings41
Buy / Hold / Sell27 / 8 / 6
Average target$220.20
Close is 63.4% of the average target; implied upside is 57.7%.
Target range$75–$800
Stock map · Aug. 26 close
| Reference | Price | Distance |
|---|---|---|
| 52-week high · June 16 | $225.64 | −38.1% |
| Average analyst target | $220.20 | +57.7% |
| Aug. 26 close | $139.63 | Base |
| IPO price · June | $135.00 | +3.4% |
| 52-week low · Aug. 3 | $104.83 | +33.2% |
Investor bridge
Louisiana expands Starship launch capacity for three revenue engines: external launch services, Starlink deployment and orbital AI infrastructure. The $100 billion headline equals all June liquidity and 3.5 times first-half capex.
Starship cadenceStarlink capacityAI satellitesExecution risks
No annual spending schedule, financing plan or return target was disclosed. Starship reusability, permits, wetland mitigation and launch demand must advance before the campus can earn a return.
engineeringregulationcash burnenvironmentProject checkpoints
| Checkpoint | Timing | What investors need |
|---|---|---|
| Phased budget | Not disclosed | Annual cash use, debt and partner funding |
| Permits and wetlands plan | Pre-construction | Schedule certainty and mitigation cost |
| Construction start | Expected 2027 | Evidence the plan is funded and active |
| Starship scale-up | Ongoing | Reliability, reusability and lower launch cost |
| First Louisiana launch | Targeted 2029 | Capacity begins supporting revenue channels |
Sources: Louisiana Economic Development’s Aug. 25 announcement; SpaceX Q2 2026 results; Reuters; WSJ delayed quote; Yahoo Finance Most Active; MarketBeat analyst record. Calculations use the Aug. 26 regular close and approximately $1.84 trillion quoted market value.
Oracle Shares Rise 2.8%, Market Value Grows by $12 Billion as Citi Highlights Key Catalysts Over Next 90 Days
New York, August 26, 2026, 19:49 – Oracle shares climbed 2.8%, increasing the company’s market capitalisation by $12 billion after Citi pointed to catalysts expected within the next 90 days.
Oracle: a $12 billion relief rally
Market snapshot: August 26, 2026, 19:49 EDT (August 27, 01:49 CEST). Regular-session figures unless noted.
Close
$148.87
+2.84%
Latest regular session
Value added
≈$12.0bn
Estimated from current shares
Market value
$433.5bn
August 26 close
Volume
18.4m
≈57% of recent average
The drawdown still dominates
Citi's 90-day setup
$330 target
+121.7% versus Wednesday's close
Forced selling may be fading.Credit spreads need to stabilize.At-the-market issuance remains a dilution test.Cloud delivery must turn backlog into billed revenue.
Fiscal 2026 growth engine
| Metric | Value | Growth |
|---|---|---|
| Total revenue | $67.4bn | +17% |
| Total cloud | $34.0bn | +39% |
| Cloud infrastructure | $18.1bn | +77% |
| Cloud applications | $15.9bn | +11% |
| RPO | $638bn | +363% |
RPO equals about 9.5 times annual revenue, but converts over several years.
Cash-flow bridge
| Operating cash flow | $32.0bn |
| Capital expenditure | −$55.7bn |
| Free cash flow | −$23.7bn |
| FY26 debt raised | $43bn |
| FY26 equity raised | $5bn |
| Planned FY27 financing | ≈$40bn |
Planned FY27 financing includes a previously announced $20bn at-the-market equity program.
Large-cap software and cloud tape
| Company | Close | Daily move | Market value | P/E |
|---|---|---|---|---|
| Oracle | $148.87 | +2.84% | $433.5bn | 26.7× |
| Microsoft | $496.37 | +0.91% | $3.70tn | 29.5× |
| Alphabet | $342.00 | −1.40% | $4.18tn | 17.2× |
| SAP ADR | $211.68 | −2.45% | $247.1bn | — |
August 26 U.S. close; latest trade timestamps ranged from 19:15 to 19:38 EDT.
Analyst range
$263.97
Average target across 39 analysts tracked by MarketBeat.
| Low | $145 |
| Average | $263.97 |
| High | $400 |
| Average implied upside | 77.3% |
What moved attention
August 26
Citi opened a positive 90-day catalyst watch. Oracle also held a financial analyst meeting at 10:45 CT.
Next 90 days
Investors will test cloud-capacity delivery, financing costs and signs that the historic selloff is losing force.
Investor scorecard
Backlog conversion: growth in cloud revenue versus the $638bn RPO balance.Capacity: new data-center and GPU deployment milestones.Cash: capital spending against operating cash generation.Funding: debt spreads, equity issuance and credit-rating pressure.
Risk register
| Risk | Investor transmission | Watch point |
|---|---|---|
| Build delays | Defers contracted revenue | Capacity delivery |
| Negative cash flow | Raises external-funding needs | Capex and OCF |
| Equity issuance | Dilutes existing holders | $20bn ATM program |
| Credit pressure | Increases financing costs | Spreads and ratings |
| Customer concentration | Raises contract and renewal sensitivity | RPO mix |
Sources: Oracle investor relations, Citi commentary reported August 26, Yahoo Finance, MarketBeat and consolidated U.S. market data. Market-value changes and peak-value gaps are estimates using the current implied share count; rounding may create small differences.
IREN Shares Rise 3.2% After Hours, Reducing Pre-Earnings Loss of $940 Million by Half
IREN Limited shares regained half of their decline from the regular session in after-hours trading on Wednesday. The stock climbed 3.21% to $40.85 at 19:34 EDT, having earlier finished the day 6.23% lower at $39.58.
IREN: the earnings-day setup
Market snapshot: August 26, 2026, 19:34 EDT (August 27, 01:34 CEST). Prices after the U.S. regular close.
Regular close
$39.58
−6.23%
4:00:01 p.m. EDT
After hours
$40.85
+3.21%
7:34:29 p.m. EDT
Implied late value
$14.60bn
About 357.4m implied shares
Volume
37.45m
82.2% of 45.55m three-month average
One session, three valuation points
The regular decline erased an estimated $940m. Late trading recovered about $454m, leaving roughly $486m below Tuesday's value.
What the late valuation assumes
<3.7×
Implied after-hours market value divided by management's above-$4bn year-end AI Cloud ARR target.
Contract coverage
About 85% of the target ARR is under contract. Weighted average term: roughly four years.
GPU-capex prepayments
Customer prepayments cover about 45% of associated GPU capital spending.
Thursday's estimate range
| Provider | Revenue | EPS |
|---|---|---|
| MarketBeat | $132.00m | −$0.55 |
| Zacks preview | $138.89m | −$0.80 |
These are separate provider forecasts, not a blended consensus. Results: August 27. Call: 5:00 p.m. EDT.
Last reported quarter
| Metric | Q3 FY26 | Q2 FY26 | Seq. |
|---|---|---|---|
| Revenue | $144.8m | $184.7m | −21.6% |
| Adjusted EBITDA | $59.5m | $75.3m | −21.0% |
| Net income/(loss) | −$247.8m | −$155.4m | Wider loss |
Quarter ended March 31, 2026. Lower Bitcoin prices and mining-hardware retirements weighed on results.
AI Cloud execution map
New contracts
$2.8bn
Multiyear AI Cloud agreements disclosed July 20
2026 delivery
480 MW
Up from roughly 3 MW
2027 target
1.2 GW
Planned energized capacity
June cash
$7.6bn
Includes $1.7bn restricted cash
U.S.-listed AI infrastructure peers
| Company | Close | Move | Value | Volume |
|---|---|---|---|---|
| IREN | $39.58 | −6.23% | $14.15bn | 37.45m |
| CoreWeave | $88.01 | −0.03% | $48.54bn | 12.13m |
| Nebius | $213.93 | −3.62% | $58.16bn | 9.17m |
August 26 U.S. regular close. Source: Yahoo Finance.
Analyst expectations
$83
Average target across 21 analysts tracked by MarketBeat.
| Low | $46 |
| Average | $83 |
| High | $105 |
Pre-results snapshot. Targets can change rapidly after earnings.
The four numbers that matter next
AI Cloud billed revenue: evidence that contracted ARR is converting on schedule.Deployment milestones: progress toward 480 MW during 2026.Funding bridge: remaining GPU capex after customer prepayments and restricted cash.Mining drag: the effect of Bitcoin prices and hardware retirements on cash generation.
Risk register
| Risk | Transmission to investors | Watch point |
|---|---|---|
| Delivery delay | Pushes contracted ARR recognition outward | Energization and GPU-install dates |
| Capital intensity | Raises financing or dilution risk | Capex, prepayments and unrestricted cash |
| Customer concentration | Increases renewal and counterparty sensitivity | New contract mix |
| Mining volatility | Obscures the AI Cloud transition | Bitcoin economics and retired capacity |
Sources: IREN filings and releases, Yahoo Finance, MarketBeat and Zacks. Market-value changes are estimates derived from Yahoo's August 26 closing price and market capitalization. Figures may differ because of rounding and after-hours liquidity.
Marvell Shares Jump 3.6% After Hours; Options Market Signals $22 Billion Earnings Move
SANTA CLARA, California, August 26, 2026, 18:04 – Marvell Technology stock gained 3.6% in after-hours trading, with options traders positioning for an anticipated $22 billion swing tied to the company’s upcoming earnings release.
NASDAQ:MRVL · Company · Stock move
Marvell: a $22 billion earnings hinge
Market snapshot: August 26, 2026, 18:03:50 EDT
After hours +3.62%
After-hours price
$253.97
+$8.86 from the close
Value added after close
≈$8.0B
Implied market cap ≈$228.2B
Options move
±10%
≈$22.0B from closing value
Q2 revenue consensus
$2.71B
About +35% year over year
Price path
Regular close: August 26 at 16:00:01 EDT. After-hours quote: 18:03:50 EDT. Total gain from the prior close: 5.65%.
What options are pricing
From the after-hours price, the options upper bound offered 6.2% upside. The lower bound represented 13.1% downside. The skew shows how Wednesday’s late rally consumed much of the bullish move.
Recent options signal published August 24, 2026; range recalculated from the August 26 closing price.
Fiscal Q2 setup
| Metric | Expectation / guide | Change |
|---|---|---|
| Revenue consensus | $2.71B | ≈+35% YoY |
| Adjusted EPS consensus | $0.93 | +38.8% YoY |
| Company revenue guide | $2.70B ±5% | +11.7% QoQ midpoint |
| Adjusted EPS guide | $0.93 ±$0.05 | $0.88–$0.98 |
| Non-GAAP gross margin | 58.25%–59.25% | 58.9% in Q1 |
| Diluted share count | 915M expected | Company guide |
Prior-quarter base
Q1 revenue growth
+28%
Q2 expected growth
+35%
Q1 non-GAAP GM
58.9%
Fiscal Q1 revenue was a record $2.418 billion. Non-GAAP net income reached $718 million, while operating cash flow hit a record $638.8 million.
The key test is conversion: exceptional AI bookings must become revenue without pushing gross margin below the guided range.
Valuation and analyst bar
| Measure | Value | Read-through |
|---|---|---|
| Trailing P/E | 84.2× | Premium leaves little room for a weak guide |
| Closing market cap / Q2 revenue | 81.3× | One quarter, not an annual multiple |
| Annualized Q2 price/sales | ≈20.3× | Assumes the quarter repeats |
| Yahoo one-year target | $266.36 | +4.9% from after-hours price |
| Susquehanna target | $265 | Positive; +4.3% from after hours |
| Rosenblatt target | $300 | Buy; +18.1% from after hours |
Price, P/E and consensus-target snapshot: August 26, 2026, 18:03:50 EDT. Fresh brokerage targets were reported August 25.
Google agreement: revenue versus dilution
Potential sales
Up to $120B
Warrant shares
58.97M
Q2 share dilution
6.4%
Google can buy the warrant shares at $206.58. Most vest only when product-purchase thresholds are met through fiscal 2033. Dilution is therefore tied to sales conversion.
Peer valuation at the August 26 close
| Company | Session move | Trailing P/E |
|---|---|---|
| Marvell | +1.97% | 84.2× |
| Nvidia | −1.52% | 31.9× |
| Broadcom | −0.33% | 97.6× |
| AMD | +0.36% | 123.6× |
Marvell sits between Nvidia and higher-multiple custom-compute peers. Its earnings must validate optical-networking growth and the custom-silicon pipeline.
Peer close data retrieved August 26, 2026, 17:52 EDT.
Thursday checklist
- Fiscal-year revenue guidance and any raise.
- Optical-interconnect sequential growth.
- Custom XPU and Google-linked revenue timing.
- Gross margin versus the 58.25%–59.25% range.
- Operating cash conversion after the Q1 record.
- Celestial AI and XConn acquisition contribution.
Risk map
Expectations: An in-line quarter may not support the multiple.
Margin: Memory and optical-component costs can compress profitability.
Execution: Custom silicon ramps require long design and qualification cycles.
Dilution: Google warrants equal 6.4% of guided diluted shares.
Tape: Regular volume was only 39% of the three-month average.
Next confirmed catalyst
Fiscal Q2 2027 results and conference call — August 27, 2026, 16:45 EDT. The market will compare any guidance raise with a $228 billion implied after-hours valuation and the 10% options move.
Sources: Yahoo Finance · Marvell Q1 results · Marvell event notice · Investopedia · Reuters
Nutanix Shares Rise 7.2% With Market Value Up $1.27 Billion After FY2027 Guidance Maintained
Nutanix Inc. shares rose 7.2% in after-hours trading on Wednesday. The hybrid-cloud firm surpassed analyst forecasts for both revenue and profit in the quarter.
NASDAQ: NTNX · Earnings reaction
Nutanix investor dashboard
Market data: Aug. 26, 2026, 17:22 EDT
Financials: quarter ended July 31, 2026
Financials: quarter ended July 31, 2026
After-hours price
$70.10
+$4.71 · +7.20%
Equity value added
$1.27B
Estimated from 270.32M shares
Trading activity
4.66M
1.88× 2.48M average volume
52-week position
74%
$34.01 low · $82.42 high
Quarterly surprise
| Metric | Actual | Consensus | Beat |
|---|---|---|---|
| Revenue | $757.1M | $738.3M | +$18.8M |
| Adjusted EPS | $0.60 | $0.49 | +$0.11 |
Growth and margin
Q4 FY2025Q4 FY2026
Operating scoreboard
| Metric | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Revenue | $757.1M | $653.3M | +16% |
| ARR | $2.55B | $2.20B | +16% |
| Adj. gross margin | 87.7% | 88.3% | −60 bps |
| Adj. operating margin | 26.2% | 18.3% | +790 bps |
| Free cash flow | $277.6M | $207.8M | +34% |
Fiscal 2027 guide
Revenue$3.18B–$3.23B
Midpoint growth12.5%
Adj. operating margin24%–25%
Free cash flow$850M–$950M
Q1 revenue$755M–$765M
Q1 adj. operating margin26%–28%
Implied market cap
$18.95B
At $70.10 after hours
FY27 sales multiple
5.9×
Using $3.205B midpoint
FY27 FCF multiple
21.1×
Using $900M midpoint
Analyst setup
Moderate Buy
18 ratings · $64.21 mean target before results
What moved the stock
Revenue exceeded consensus by 2.5%. Adjusted operating margin expanded 790 basis points. ARR kept pace with quarterly revenue at 16% growth. Fiscal-2027 guidance preserved double-digit sales growth while keeping adjusted operating margin near one quarter of revenue.
Risk monitor
Adjusted gross margin fell 60 basis points. Server supply constraints can delay deployments and cash collection. The after-hours price already exceeds the pre-report average analyst target. Extended-hours liquidity can exaggerate moves.
Sources: Nutanix fiscal Q4/FY2026 release; MarketBeat earnings estimates and analyst consensus; StockAnalysis after-hours quote and share data. Valuation figures are calculated estimates. Prices and volume are time-sensitive.
Synopsys Shares Drop 2.8%, Wiping Out $2.2 Billion After Upgraded AI-Driven Outlook
SUNNYVALE, California, August 26, 2026, 17:27 — Synopsys slipped 2.8%, losing $2.2 billion in market value, after the company raised its forecast bolstered by AI-related business.
NASDAQ: SNPS · Company · Stock move · Earnings
Synopsys: a beat, a raise, and a $2.2B valuation warning
AI demand strengthened the numbers. The after-hours tape said the size of the raise still mattered.
August 26, 2026
17:31 EDT · After hours
17:31 EDT · After hours
After-hours price
$398.65
−2.77% · −$11.35
Regular close: $410.00
Equity value erased
$2.17B
After-hours
191.48M shares × $11.35
Q3 revenue
$2.477B
+42.4% YoY
1.6% above consensus
Adjusted EPS
$3.91
+6.5% vs estimate
$3.67 consensus · $3.39 YoY
The market's message
The quarter beat. The forecast raise was modest.The annual revenue midpoint increased by roughly $45M, or 0.47%. At about 95× trailing earnings, a small upgrade left little room for upside surprise.
Regular closePost-earnings move
Trading snapshot
Regular range$403.54–$419.60
Volume2.51M
Average volume1.81M
Volume vs average+38.7%
Market cap at close$78.51B
Trailing P/E95.0×
Where growth came from
Design Automation revenue$2.003B · +52.7%
80.9% of Q3 revenue · includes Ansys
Design IP revenue$473.8M · +10.8%
19.1% of Q3 revenue · returned to YoY growth
Margin signal
Non-GAAP operating margin41.6%
Design Automation margin45.2% · +70 bp
Design IP margin26.5% · +640 bp
GAAP operating margin14.4%
Large acquired-intangible amortization keeps the GAAP and adjusted views far apart.
Guidance bridge
| Metric | Prior | New | Midpoint change |
|---|---|---|---|
| FY2026 revenue | $9.63B–$9.71B | $9.69B–$9.74B | +$45M · +0.47% |
| FY2026 adjusted EPS | $14.72–$14.80 | $15.04–$15.10 | +$0.31 · +2.1% |
| Q4 revenue | — | $2.53B–$2.58B | New range |
| Q4 adjusted EPS | — | $4.10–$4.16 | New range |
| FY2026 free cash flow | — | ~$2.60B | 26.8% of revenue midpoint |
Catalyst scorecard
Revenue beatEPS beatGuide raisedIP growth restoredPositiveAI-led EDA demand
PositiveAnsys quarter
WatchOrganic mix
PressurePremium valuation
Analyst setup before revisions
Buy / Hold / Sell11 / 3 / 0
Average target$571.92
Upside from close39.5%
Target range$450–$650
Pre-earnings snapshot. New notes can change the distribution.
Peer valuation
Synopsys P/E95.0×
Cadence P/E66.6×
SNPS premium42.7%
SNPS AH move−2.77%
CDNS AH move+0.55%
What investors should watch next
1 · Design IP
Sequential growth in Q4Confirms that the recovery extends beyond one quarter.
2 · Ansys integration
$2.98B expected FY revenueSynergies must offset amortization, restructuring and leverage.
3 · Multiple support
95× trailing earningsHigh expectations make the stock sensitive to modest raises.
Sources: Synopsys fiscal Q3 2026 results; Reuters; Google Finance. Market figures timestamped August 26, 2026, 17:31 EDT. Price data may be delayed. Calculations use disclosed figures and may differ slightly because of rounding.
Nvidia Shares Drop 1.8% Following $96.2 Billion Quarterly Revenue, With AI Commitments Now at $366 Billion
SANTA CLARA, California, August 26, 2026, 16:30 EDT — Nvidia stock declined by 1.8% after reporting quarterly revenue of $96.2 billion, as the company’s total AI-related commitments reached $366 billion.
NVIDIA · NASDAQ:NVDA · Q2 FY2027
Revenue beat, balance-sheet test
Market data: Aug. 26, 2026, 16:30 EDT
Financials: quarter ended July 26, 2026
Financials: quarter ended July 26, 2026
After hours
$205.92 · -1.78%
Close $209.66 · about $90B value erased
Q2 revenue
$96.22B
+106% YoY · +4.2% vs FactSet consensus
Q3 outlook
$108.0B
+3.6% vs $104.2B consensus · ±2% range
Commitments + guarantees
$474.5B
8.4× cash and marketable debt securities
Revenue acceleration
Q2 Data Center revenue was $89.0B, or 92.5% of total sales.
Investor bridge
| Measure | Value | Signal |
|---|---|---|
| Adjusted EPS | $2.22 | +6.2% vs est. |
| Q2 gross margin | 75.0% | Flat QoQ |
| Q3 gross margin | 74.0% | -1.0 pt |
| Free cash flow | $21.34B | -56% QoQ |
| DSO | 60 days | +15 days |
Commitment stack
Supply and capacity · $279B
Other contractual commitments · $87B
Contingent guarantees · $108.5B
Supply commitments rose $160B, or 134%, in one quarter. The guarantee total includes $105B for the Ohio site and $3.5B for AI-cloud leases.
Operating signals
| Metric | Q2 FY27 | Sequential | Why it matters |
|---|---|---|---|
| Data Center | $89.0B | +18% | Core demand remains strong |
| ACIE | $40.3B | +25% | Faster than hyperscale |
| Receivables | $63.1B | DSO 45→60 | Cash conversion slowed |
| Inventory | $31.6B | +22% | Rubin launch build |
| Operating cash flow | $24.1B | -52% | Working capital and taxes |
What changes the thesis
Bull: $108B revenue converts to cashBull: ACIE sustains 25% QoQ growthBear: margin falls below 73.5%Bear: DSO extends againBear: customer guarantees activate
Commitments are future obligations, not immediate debt. Guarantees are contingent. The valuation test is whether Nvidia's revenue and free cash flow scale faster than supply, lease and customer-support exposure.
Generate Biomedicines Stock Slides 20% as 103 Million Shares Clear Lock-Up
Generate Biomedicines Inc. shares fell 20.3% to $16.25 at 15:06 EDT. The decline erased about $530 million of quoted equity value.
NASDAQ: GENB · Investor dashboard
Lock-up supply resets the valuation debate
A 103.14 million-share resale block became eligible as Generate Biomedicines returned near its $16 IPO price. The September 8 GB-0895 data now become the next fundamental test.
Market snapshot
Aug. 26, 2026 · 15:06 EDT
Aug. 26, 2026 · 15:06 EDT
STOCK MOVELOCK-UP
Share price
$16.25
Aug. 26, 15:06 EDT
Session move
−20.3%
−$4.13 per share
Volume
3.06M
3.4× 3-month average
Market value
$2.09B
At 15:06 EDT
Information gain: the day’s $4.13 decline erased roughly $530 million of quoted equity value. The unlocked block itself was worth about $1.68 billion at $16.25.
Potentially sale-eligible share pool
SEC share count: 128.27M at June 30, 2026. Eligibility does not prove actual selling.
Price path: rally, reversal, reset
Aug. 21 close
$16.12
Aug. 24 close
$17.72
Aug. 25 close
$20.38
Aug. 26, 15:06
$16.25
GENB rose 26.4% from Aug. 21 through Aug. 25, then gave back nearly the entire advance. It remained 1.6% above the $16 IPO price at 15:06 EDT on Aug. 26.
Balance-sheet and operating signals
| Metric | Latest | Investor read |
|---|---|---|
| Cash + securities | $457.4M | 21.9% of market cap |
| H1 operating cash use | $138.3M | Runway into H1 2028 |
| Q2 collaboration revenue | $6.3M | −37.7% year over year |
| Q2 net loss | $67.3M | Widened from $56.7M |
| Q2 GB-0895 external R&D | $20.5M | +54.3% year over year |
Catalyst clock
Feb. 27IPO priced at $16; 25M shares sold for $400M gross.
Aug. 25 closeRestrictions lift on 103.14M shares, subject to securities laws.
Sept. 8GB-0895 Phase 1b COPD safety, PK and PD poster at ERS 2026.
H1 2028Management’s current cash-runway horizon and planned Phase 3 enrollment window.
What changes next: ownership supply drove this session. September data can shift the focus back to GB-0895’s pharmacology and the twice-yearly dosing case.
Analyst expectations
Average target
$25.60
Six analysts
Target range
$22–$30
S&P Global poll
As of Aug. 26, 2026. Morgan Stanley reiterated Buy with a $22 target on Aug. 17; Piper Sandler reiterated Buy with a $24 target on Aug. 7.
Investor frame
Bull case: little actual lock-up selling would make the 20% drop look like a temporary supply discount. Positive COPD data could strengthen the six-month dosing proposition ahead of larger severe-asthma readouts.
Risk case: sustained insider or venture-holder sales could cap rebounds. Weak September pharmacology, faster cash use, or Phase 3 delays would raise financing and dilution risk before commercialization.
Mitsubishi Motors Shares Up 2.5% Before 2027 Pajero Launch
Mitsubishi Motors is set to debut the 2027 Pajero on September 2. The flagship SUV makes a comeback to international markets after a five-year absence. Shares of Mitsubishi Motors Corporation finished Wednesday at ¥374.70, rising 2.52%.
Product catalyst · TYO:7211
2027 Mitsubishi Pajero
Flagship SUV return meets a low-margin growth plan.
Market data: August 26, 2026, 15:30 JST · Dashboard: August 27, 2026, 03:42 JST
Close
¥374.70
▲ 2.52%
Tokyo close, Aug. 26
Session volume
8.57M
shares traded
Market value
¥501.6B
approximate; 1.34B shares
Analyst target
¥372.83
0.5% below the close
Wednesday's price action
Open¥364.20
Low¥362.00
High / close¥374.70
Equity-value gain≈¥12.3B
Equity-value change uses the ¥9.20 share gain and 1.34 billion shares outstanding.
Fiscal 2026 operating frame
Retail volume857,000 · +8%
Net sales¥3.26T · +13%
Operating profit¥90B · +19%
Operating margin2.8% vs. 2.6%
Sensitivity: 10 basis points of margin on ¥3.26 trillion equals ¥3.26 billion, or 3.6% of guided operating profit.
Pajero commercial signal
| Signal | Verified measure |
|---|---|
| Global return | After 5 years |
| Lifetime sales | >3.25M units |
| Historical markets | >170 |
| Dakar record | 12 wins |
| Platform | Triton ladder frame |
| Drive control | S-AWC |
Lifetime Pajero sales equal 3.8 times Mitsubishi's current full-year volume target.
What the market still needs
AUG 24
Teaser updateReveal date and triple multi meter confirmed.
SEP 2
World premierePricing, powertrain and initial markets are key.
H2 FY26
Launch phaseManagement links Pajero to sales growth.
FY26
Plan test857,000 retail units and 2.8% margin.
Risk watch: procurement and shipping are a ¥28.7 billion headwind. Delays, discounting or costly launch inventory would press a narrow margin target.
Analyst expectations
2 Buy7 Hold3 Sell12-analyst poll, accessed August 26
Target range¥330–¥500
Average target¥372.83
52-week trading range¥300.70–¥458.00
Sources: Mitsubishi Motors official Pajero site and releases; Mitsubishi Motors Q1 presentation summary; StockAnalysis and Investing.com market and consensus data. Currency is Japanese yen. Estimates are explicitly marked.
Boston Scientific Shares Drop 4.1% After Cyberattack Threatens Up to $369 Million in Q3 Revenue
NEW YORK, August 26, 2026, 09:40 – Shares of Boston Scientific fell 4.1% after the company disclosed that a cyberattack may endanger as much as $369 million in third-quarter sales.
NYSE: BSX · Cyberattack monitor
Boston Scientific
Order-processing and shipment disruption meets a reduced 2026 growth outlook.
Market snapshot
Aug. 26, 2026 · 09:40:21 EDT
Aug. 26, 2026 · 09:40:21 EDT
Share price
$47.81
−4.11% · −$2.05
Open $47.00 · range $46.90–$48.53
Quoted value lost
$2.97B
Estimated from 1.45B shares outstanding
Q3 revenue guide
$5.22–$5.32B
3%–5% growth vs. Q3 2025
Revenue risk scenario
$316–$369M
Evercore: 600–700 bp if recovery mirrors Stryker
Market repricing versus modeled sales exposure
The stock-market loss equals roughly 8.0×–9.4× the analyst's modeled revenue exposure.
Market valueLow scenarioHigh scenario
What moved the stock
Company detects a cybersecurity incident.
Discloses global disruption, including systems that process and ship orders.
Shares open at $47.00, 5.74% below prior close.
BSX trades at $47.81, down 4.11%.
Operating base
| Metric | Q2 2026 | YoY |
|---|---|---|
| Total sales | $5.442B | +7.5% |
| Cardiovascular | $3.624B | +8.3% |
| MedSurg | $1.818B | +5.9% |
| Adjusted EPS | $0.86 | +14.7% |
| GAAP net income | $907M | +13.8% |
Guidance and valuation
| Signal | Current reading |
|---|---|
| FY26 sales growth | 5.5%–6.5% reported |
| FY26 adjusted EPS | $3.28–$3.32 |
| Q3 adjusted EPS | $0.80–$0.82 |
| P/E | 19.38× |
| Analyst consensus | Buy · 31 analysts |
| Average target | $62.69 · 31% upside |
Scenario frame
| Recovery path | Revenue effect | Investor implication |
|---|---|---|
| Faster than Stryker | Below $316M | More orders may shift within the quarter rather than disappear. |
| About three weeks | $316M–$369M | Evercore's 600–700 bp scenario; a guide cut becomes plausible. |
| Longer or broader | Above $369M | Margin pressure and customer disruption could outlast shipment delays. |
Risk check
Boston Scientific has not determined whether the incident is reasonably likely to be material. The full scope, recovery duration and any data loss remain unknown.
Watch next: recovery timetable, shipment resumption, order recapture, guidance update.
Sources: Boston Scientific Q2 2026 results; Reuters, Aug. 26, 2026; Google Finance quote at 09:40:21 EDT; StockAnalysis analyst consensus. The $316M–$369M range is a scenario calculation, not company guidance.
Callaway Golf shares slip 2% amid $430 million equipment division’s exposure to Quantum Driver ad campaign
CARLSBAD, California, August 26, 2026, 05:45 – Callaway Golf stock declined 2% on Wednesday following market reaction to ad pull testing related to its Quantum Driver, putting the company’s $430 million equipment segment under pressure.
Callaway Golf Company · NYSE:CALY
Quantum campaign fallout
A compact view of the stock reaction, the $699.99 co-branded driver, and the equipment segment carrying most of Callaway's quarterly revenue.
Market data: Aug. 26, 2026, 08:21:15 EDT
Financials: quarter ended Jun. 30, 2026
Financials: quarter ended Jun. 30, 2026
Aug. 25 close
$15.47
−2.03% · −$0.32
Official close, 16:00:03 EDT
Premarket
$15.56
+0.58% · +$0.09
Aug. 26, 08:21:15 EDT
Volume
1.27M
59% of 2.14M average
Aug. 25 session
Market value
$2.78B
Est. $57.1M erased
32¢ × 178.51M shares
Investor bridge: market loss versus equipment economics
Product and catalyst
Limited driver
$699.99
Good Good Quantum Triple Diamond Max, 460cc head, adjustable 10g weight.
Ad withdrawnCEO apologyTwo investigationsApproval changes
Golf Equipment — Q2 2026
| Metric | Result |
|---|---|
| Revenue | $430.3M · +4.5% |
| Operating income | $100.3M · +31.6% |
| Operating margin | 23.3% · +480 bp |
| Share of group sales | 70.3% |
Group signals
| Metric | Result |
|---|---|
| Q2 sales | $612.2M · +2.0% |
| GAAP gross margin | 50.1% · +620 bp |
| FY26 sales guide | $2.045B–$2.070B |
| FY26 adjusted EBITDA | $246M–$260M |
Analyst expectations
Consensus
Buy
| Average target | $20.50 |
| Implied upside from $15.47 | 32.5% |
| Coverage | 11 analysts |
| Rating mix | 5 Strong Buy · 5 Hold · 1 Sell |
S&P Global consensus, accessed Aug. 26, 2026.
Catalyst timeline
Aug. 21Good Good posts the co-branded driver video; it is removed within hours.
Aug. 22Good Good and Callaway issue preliminary responses.
Aug. 25Chip Brewer accepts Callaway's approval role and announces internal and external reviews.
Next evidenceProduct availability, partner actions and Callaway's next sales update.
What can change the thesis
Contained case: investigations close without retailer, media or partner withdrawals; the 0.58% premarket rebound persists. Adverse case: partner action raises campaign costs or weakens demand in a segment producing 70.3% of quarterly sales. Watch the product listing, PGA Tour decisions and management's next equipment-sales commentary.
Take-Two Faces $8.2 Billion Revenue Test with GTA 6 Netflix Launch
NEW YORK, August 26, 2026, 05:20 EDT — Take-Two Interactive’s projected $8.2 billion in bookings comes into focus as the gaming giant prepares for the Netflix premiere of Grand Theft Auto 6, a major release the company hopes will reinforce its revenue outlook.
Product catalyst · Investor dashboard
GTA VI’s Netflix preview meets Take-Two’s bookings test
A six-hour streaming exclusive concentrates attention before the November launch. The financial question is conversion, not trailer views.
Market data: Aug. 25, 2026, 16:00 EDT
Prepared: Aug. 26, 2026, 05:20 EDT
Prepared: Aug. 26, 2026, 05:20 EDT
TTWO close
$232.93
−0.24%
Aug. 25 regular session
After hours
$233.58
+0.28%
Latest verified quote: 16:54 EDT
Equity value
$43.55B
Approximate market capitalization
Netflix head start
6 hours
3 p.m. to 9 p.m. EDT, Aug. 27
The event
Grand Theft Auto VI: An Extended Look premieres to Netflix members at 3 p.m. EDT Thursday.
Public release9 p.m. EDT · YouTube + GTA VI site
Game launchNov. 19, 2026
Standard / Ultimate$79.99 / $99.99
Edition premium25.0%
Fiscal 2027 bookings bridge
Q1 bookings$1.39B
Full-year guidance$8.0B–$8.2B
Still required after Q1$6.61B–$6.81B
Q1 equals 17.2% of the $8.1B guidance midpoint. GTA VI launches during the fiscal year.
Price position inside 52-week range
The average analyst target sits above the current 52-week high. That requires execution beyond a successful marketing event.
Franchise scale
470M+
Grand Theft Auto units sold-in worldwide
GTA V alone230M+
Preorders“Unprecedented”
Published unitsNot disclosed
Illustrative launch spending
| Units | Standard | Ultimate |
|---|---|---|
| 10M | $0.80B | $1.00B |
| 25M | $2.00B | $2.50B |
| 50M | $4.00B | $5.00B |
Gross consumer spending before platform fees, tax, refunds and edition mix. Not company guidance.
Analyst expectations
Strong Buy| Buy / Hold / Sell | 27 / 0 / 1 |
| Average target | $286.89 |
| Implied upside | 23.2% |
| Low / High | $170 / $368 |
Why investors care
Take-Two needs a sales curve, not merely a cultural moment.
Preview qualityA weak showcase may slow preorder momentum.
ConversionSix hours of exclusivity may not produce measurable subscriptions.
ScheduleAnother delay would push bookings and cash flow outward.
VisibilityPreorder units remain undisclosed and cancellable.
Sources: Take-Two investor relations and preorder release; Netflix Tudum; Reuters; StockAnalysis; Investing.com. Scenario calculations are illustrative. Prices are in U.S. dollars.
TechStock² Updates
![Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]](https://ts2.tech/wp-content/uploads/2026/08/Asia-market-dashboard-2026-08-28-0051-480x384.jpg "Asia Stock Market Today 28/08/2026 [UPDATE: 00:51 SGT] [Salesforce Leads KASE Global Into Final Minutes After Asia’s Split Close]")
